NovoCure Ltd — Director's Dealing 2020

Mar 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-03-06

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-06	Restricted Share Units	S	2906	$69.534	Disposed	86438	Direct
2020-03-06	Ordinary Shares	M	17500	$7.48	Acquired	103938	Direct
2020-03-06	Restricted Share Units	S	3245	$64.27	Disposed	100693	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-06	Options to Buy Ordinary Shares	$7.48	M	17500	Disposed	2024-02-25	Ordinary Shares (17500.0)	Direct

Footnotes

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on March 5, 2020. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.

F3: Fully vested as of the date hereof.